Otis Clapp Back Quell Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Otis Clapp Back Quell
Z
- Zafemy (ethinyl estradiol / norelgestromin)
- Zagam (sparfloxacin)
- Zagam Respipac (sparfloxacin)
- Zantac (ranitidine)
- Zarah (drospirenone / ethinyl estradiol)
- Zavara (cholecalciferol / folic acid)
- Zcort (dexamethasone)
- Zebeta (bisoprolol)
- Zebutal (acetaminophen / butalbital / caffeine)
- Zee-Seltzer Antacid and Pain Reliever (aspirin/citric acid/sodium bicarbonate)
- Zegerid (omeprazole / sodium bicarbonate)
- Zegerid (Original Formulation) (omeprazole)
- Zegerid OTC (omeprazole / sodium bicarbonate)
- Zejula (niraparib)
- Zelboraf (vemurafenib)
- Zema Pak (dexamethasone)
- Zemdri (plazomicin)
- Zemplar (paricalcitol)
- Zenapax (daclizumab)
- Zenchent (ethinyl estradiol / norethindrone)
- Zenchent Fe (ethinyl estradiol / norethindrone)
- Zeosa (ethinyl estradiol / norethindrone)
- Zero-Order Release (aspirin)
- Zestoretic (hydrochlorothiazide / lisinopril)
- Zestril (lisinopril)
- Ziac (bisoprolol / hydrochlorothiazide)
- zidovudine
- Zilretta (triamcinolone)
- Zinbryta (daclizumab)
- ZoDex (dexamethasone)
- Zolate (cholecalciferol / folic acid)
- zoledronic acid
- Zoloft (sertraline)
- Zometa (zoledronic acid)
- Zonacort (dexamethasone)
- Zorcaine (articaine / epinephrine)
- ZORprin (aspirin)
- Zovia 1 / 35 (ethinyl estradiol / ethynodiol)
- Zovia 1 / 35E (ethinyl estradiol / ethynodiol)
- Zovia 1 / 50E (ethinyl estradiol / ethynodiol)
- Zumandimine (drospirenone / ethinyl estradiol)
- Zydelig (idelalisib)
- Zykadia (ceritinib)
- Zyloprim (allopurinol)
- Zynrelef (bupivacaine / meloxicam)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.